CP-4055

· Clavis Pharma

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for CP-4055, covering 2009-06-04 to 2013-09-18. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies [Phase 1, Phase 2]